Background: The 2025/26 influenza season included A(H3N2) subclade K predominance with A(H1N1)pdm09 co-circulation and subsequent prolonged influenza B activity. The Canadian Sentinel Practitioner Surveillance Network reports vaccine effectiveness (VE) in the context of genetic and antigenic relatedness to circulating viruses. Methods: We estimated VE by test-negative design among outpatients with medically-attended acute respiratory illness between November and April.
2025/26 subclade-specific influenza A and B vaccine effectiveness estimates and discordant laboratory-based indicators of vaccine match or mismatch
calendar_today
September 12, 2026
person
Separovic, L., Kaweski, S. E., Cox, M. B., Zhan, Y., Sabaiduc, S., Olsha, R., Hasso, M., Mather, R. G., Carazo, S., Lacroix, C., Meunier, I., Salhi, L. N., Dickinson, J. A., Zelyas, N., Jassem, A. N., Dover, K., Ranadheera, C., Gao, R., Bastien, N., Skowronski, D. M.
domain
medrxiv